Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04140669 · ClinicalTrials.gov registry record
Automated Myocardial Performance Index Using Samsung HERA W10
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 7
- Enrollment target
NCT04140669: Clinical Trial study, sponsored by Mayo Clinic.
NCT04140669 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04140669 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Researchers are using Myocardial performance index (MPI) to assess fetal cardiac function before, during, and after fetal surgery in order to gain more knowledge about fetal cardiac function in high risk pregnancies and the relationship to outcomes of fetal surgical interventions.
Interventions
- DEVICE Automated Myocardial Performance Index (MPI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2020-07-07 |
Why NCT04140669 stopped before completion
NCT04140669 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Automated Myocardial Performance Index (MPI) is the first listed.
NCT04140669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04140669 about?
NCT04140669 is a clinical study titled "Automated Myocardial Performance Index Using Samsung HERA W10". Researchers are using Myocardial performance index (MPI) to assess fetal cardiac function before, during, and after fetal surgery in order to gain more knowledge about fetal cardiac function in high risk pregnancies and the relationship to outcomes of fetal surgical interventions.
What is the current status of trial NCT04140669?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2019-09-16. Estimated completion is 2020-07-07.
What interventions are being tested in trial NCT04140669?
The interventions under investigation include: Automated Myocardial Performance Index (MPI) (DEVICE).
Who is sponsoring clinical trial NCT04140669?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI